Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 71 (1) , 238-242
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of cardiopulmonary bypass temperature on pulmonary gas exchange after coronary artery operationsThe Annals of Thoracic Surgery, 1996
- Leukocyte and platelet depletion with a blood cell separator: Effects on lung injury after cardiac surgery with cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Platelet‐activating factor: a mediator for cliniciansJournal of Internal Medicine, 1995
- The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: A clinical studyThe Journal of Thoracic and Cardiovascular Surgery, 1995
- A signal terminatorNature, 1995
- Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Respiratory dysfunction after uncomplicated cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Variations in blood platelet‐activating‐factor levels after protamine reversal of heparin in humansActa Anaesthesiologica Scandinavica, 1992
- Neutrophil‐mediated Vascular InjuryActa Medica Scandinavica, 1987
- The Effect of Surgery with Cardiopulmonary Bypass on Alveolar-Capillary Barrier Function in Human BeingsThe Annals of Thoracic Surgery, 1985